BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 6869590)

  • 1. Kinetic constants of platelet monoamine oxidase in schizophrenia.
    Jackman HL; Meltzer HY
    Am J Psychiatry; 1983 Aug; 140(8):1044-7. PubMed ID: 6869590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients.
    Meltzer HY; Duncavage MB; Jackman H; Arora RC; Tricou BJ; Young M
    Am J Psychiatry; 1982 Oct; 139(10):1242-8. PubMed ID: 6127035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some kinetic parameters of platelet monoamine oxidase in chronic schizophrenia.
    Kobes RD; Potkin SG; Wise CD; Bridge TP; Neckers LM; Wyatt RJ
    Psychiatry Res; 1979 Oct; 1(2):179-85. PubMed ID: 298347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
    Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM
    Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet monoamine oxidase activity in schizophrenic patients.
    Becker RE; Shaskan EG
    Am J Psychiatry; 1977 May; 134(5):512-7. PubMed ID: 848577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous modulation of monoamine oxidase in schizophrenic and normal humans.
    Becker RE; Giambalvo CT
    Am J Psychiatry; 1982 Dec; 139(12):1567-70. PubMed ID: 7149055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet monoamine oxidase in chronic schizophrenic patients.
    Berger PA; Ginsburg RA; Barchas JD; Murphy DL; Wyatt RJ
    Am J Psychiatry; 1978 Jan; 135(1):95-9. PubMed ID: 618534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet MAO activity and long-term outcome in schizophrenia and schizoaffective disorder.
    Malas KL; van Kammen DP
    Am J Psychiatry; 1983 Jun; 140(6):794-6. PubMed ID: 6846644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients.
    Schildkraut JJ; Herzog JM; Orsulak PJ; Edelman SE; Shein HM; Frazier SH
    Am J Psychiatry; 1976 Apr; 133(4):438-40. PubMed ID: 1267046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delusional misidentification and platelet monoamine oxidase.
    Barton JL; Chaparala S; Barton ES; Jackson IV; Davis LG
    Biol Psychiatry; 1980 Apr; 15(2):275-82. PubMed ID: 7417616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase activity and enzyme kinetics in three subpopulations of density-fractionated platelets in chronic paranoid schizophrenics.
    Mann JJ; Kaplan RD; Georgotas A; Friedman E; Branchey M; Gershon S
    Psychopharmacology (Berl); 1981; 74(4):344-8. PubMed ID: 6794079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet monoamine oxidase: studies on the rate of heat inactivation in normal and in paranoid and nonparanoid chronic schizophrenic groups.
    Wise CD; Bridge TP; Potkin SG; Wyatt RJ
    Psychiatry Res; 1979 Oct; 1(2):187-90. PubMed ID: 298348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet monoamine oxidase activity in schizophrenic families - kinetic aspects.
    Koide Y; Sääf J; Wahlund LO; Roos SB; Wetterberg L
    Clin Genet; 1981 May; 19(5):405-9. PubMed ID: 7296931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet monoamine oxidase and plasma amine oxidase in psychiatric patients.
    Meltzer HY; Arora RC; Jackman H; Pscheidt G; Smith MD
    Schizophr Bull; 1980; 6(2):213-9. PubMed ID: 7375852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet monoamine oxidase activity in subgroups of schizophrenic disorders.
    Schildkraut JJ; Orsulak PJ; Schatzberg AF; Herzog JM
    Schizophr Bull; 1980; 6(2):220-5. PubMed ID: 7375853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet MAO Vmax and Km in chronic schizophrenic subjects.
    Giller EL; Bierer L; Rubinow D; Docherty JP
    Am J Psychiatry; 1980 Jan; 137(1):97-8. PubMed ID: 7352569
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet monoamine oxidase activity in the psychoses: relationship to symptoms and lithium response.
    Hitzemann RJ; Sautter F; Hitzemann B; Hirschowitz J; Garver DL
    Psychiatry Res; 1984 Mar; 11(3):211-21. PubMed ID: 6587414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased blood platelet MAO activity in unmedicated chronic schizophrenic patients.
    Domino EF; Khanna SS
    Am J Psychiatry; 1976 Mar; 133(3):323-6. PubMed ID: 943955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.